Association of CpG island methylator phenotype (CIMP) with inferior progression-free survival with anti-EGFR monoclonal antibody therapy in metastatic colorectal cancer.
Michael Sangmin Lee
No relevant relationships to disclose
Michael J. Overman
Research Funding - Amgen; Bristol-Myers Squibb
Dipen M. Maru
No relevant relationships to disclose
Zhi-Qin Jiang
No relevant relationships to disclose
Shanequa Manuel
No relevant relationships to disclose
Cathy Eng
No relevant relationships to disclose
Bryan K. Kee
No relevant relationships to disclose
David R. Fogelman
No relevant relationships to disclose
Chris R. Garrett
No relevant relationships to disclose
Shailesh M Advani
No relevant relationships to disclose
Eduardo Vilar Sanchez
No relevant relationships to disclose
Imad Shureiqi
No relevant relationships to disclose
Robert A. Wolff
No relevant relationships to disclose
Stanley R. Hamilton
No relevant relationships to disclose
Scott Kopetz
No relevant relationships to disclose